Silphium Asset Management Ltd Makes New $1.04 Million Investment in Intuitive Surgical, Inc. $ISRG

Silphium Asset Management Ltd purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,835 shares of the medical equipment provider’s stock, valued at approximately $1,039,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $469.21 on Monday. Intuitive Surgical, Inc. has a 52 week low of $427.84 and a 52 week high of $603.88. The firm has a market cap of $166.63 billion, a P/E ratio of 59.47, a price-to-earnings-growth ratio of 3.66 and a beta of 1.68. The firm’s 50-day simple moving average is $479.21 and its 200 day simple moving average is $515.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the prior year, the business earned $2.21 EPS. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ISRG. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Mizuho set a $525.00 price objective on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Monday, April 13th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research note on Wednesday, March 11th. Finally, Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $598.36.

Insiders Place Their Bets

In related news, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,943 shares of company stock worth $17,279,568 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and research note a very large addressable market — Intuitive forecasts procedure TAM reaching ~9M by 2026, supporting a multi‑year growth runway as robotics penetration remains low. ISRG’s Rising Procedure TAM With Low Penetration Backs Sustained Growth
• Positive Sentiment: Shares have rallied ahead of earnings on hopes that continued procedure growth and recent product adoption (da Vinci 5) will translate into a strong print and re‑rate after a weak YTD performance. Intuitive Surgical Is Jumping 2.7% Ahead of Earnings
• Positive Sentiment: RBC Capital recently reiterated a Buy, signaling continued institutional support among several bullish analyst views on ISRG’s medium‑term growth. Intuitive Surgical Receives a Buy from RBC Capital
• Neutral Sentiment: Pre‑Q1 research pieces dig into Wall Street estimates for procedure growth, service revenue and systems placements — useful context but not new catalysts on their own. Seeking Clues to Intuitive Surgical Q1 Earnings
• Negative Sentiment: BTIG trimmed its price target (citing potential headwinds from the CMS FY27 payment rule), a sign that reimbursement policy risk could pressure near‑term multiples. Price Target Lowered at BITG Amid CMS FY27 Payment Rule Impact
• Negative Sentiment: Recent headline risks — an FDA safety communication tied to certain stapler/reload products and a disclosed internal cybersecurity phishing incident — plus notable insider selling, are keeping a risk premium on the stock. Those issues have weighed on sentiment even absent fresh fundamental misses. Slides as Investors Refocus on Safety and Cybersecurity Overhangs

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.